Clinical Policy: Brensocatib (Brinsupri)
Customize your policy alerts
Sign up for Ambetter Nevada Policy CP.PMN.303 alerts
Get alerted when Policy CP.PMN.303 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity coverage of Brensocatib (Brinsupri) for Ambetter members with non-cystic fibrosis bronchiectasis. It applies to commercial, HIM/ICHRA, and Medicaid lines of business, subject to applicable state Medicaid requirements.
Coverage requires that the member does not have cystic fibrosis for non-cystic fibrosis bronchiectasis.
The health insurance marketplace/ICHRA line of business was added to the policy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.